Attapon Cheepsattayakorn1,2*, Ruangrong Cheepsattayakorn3 and Porntep Siriwanarangsun1
1Faculty of Medicine, Western University, Pathumtani Province, Thailand
210th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand
3Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
*Corresponding Author: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand.
Received: December 22, 2021; Published: January 01, 2022
B.1.1.529 or Omicron variant, a variant of concern, designated by the World Health Organization (WHO) on November 26, 2021, on the suggestion of the WHO’s Technical Advisory Group on Virus Evolution (TAG-VE) . Whether Omicron variant is more transmissible or causes more severe COVID-19 is not yet clear compared to other SARS-CoV-2 (COVID-19) variants, including Delta variant . Several epidemiological studies are ongoing in South Africa, first country of Omicron variant identification with rising of number of SARS-CoV-2 (COVID-19)-positive persons . Currently, no information on different Omicron-related symptoms is available, compared to other COVID-19 variants . Increased risk of Omicron-variant reinfection could easily occur in individuals with previous COVID-19 infection . Reverse-transcriptase-polymerase-chain reaction (RT-PCR) continuously is the method of Omicron variant detection . A recent study in England demonstrated that the vaccine efficacy (VE) after 15 weeks of two doses of BNT162b2 (Pfizer) vaccine was around 88.0 %, whereas there was no effect against Omicron variant after two doses of ChAdOx1 (AstraZeneca) vaccine . Effectiveness of current treatments currently underway .
Citation: Attapon Cheepsattayakorn., et al. “COVID-19 Vaccine Efficacy on Omicron Variant”. Acta Scientific Microbiology 5.2 (2022): 01.
Copyright: © 2022 Attapon Cheepsattayakorn., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.